The Ellipsys Vascular Access System reduces the time before patients with kidney failure can start lifesaving dialysis treatments, while requiring fewer secondary procedures, according to a new study ...

The future of healthcare is not just about treating patients when they come to the clinic. It is also about developing systems that help identify potential risks earlier and extend care beyond ...

Aditlys (http://www.aditlys.com/) is the first medical technology firm to develop a bioresorbable vascular access solution for patients undergoing dialysis treatment ...

Dallas, TX - Commenting on a study using endothelial progenitor (EP) cells to create an endothelial lining for artificial arteriovenous grafts [ 1], an editorialist suggests that hemodialysis vascular ...

Please provide your email address to receive an email when new articles are posted on . Hispanic patients were 64% less likely to receive pre-dialysis nephrology care vs. non-Hispanic white patients.

Despite declining rates of vascular access complications in the United States, Black patients remain at higher risk for them compared with White patients. Despite declining rates of vascular access ...

Planning for renal replacement therapy and dialysis vascular access requires evaluation of comorbidities and quality of life Selection of the ideal vascular access for an elderly patient requires ...

Vital Access has secured a $10 million credit facility from Deerfield Management to expand marketing of its FDA-cleared implant to make it easier to access the vascular system of end-stage renal ...

Please provide your email address to receive an email when new articles are posted on . According to recently published results, insurance-related disparities in the use of arteriovenous fistulas and ...

SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Avenu Medical, Inc. announced today that it has received De Novo marketing authorization from the Food and Drug Administration (FDA) to market its ...

Hispanic patients initiating hemodialysis in the US were less likely to receive predialysis nephrology care and had lower rates of usable vascular access at dialysis initiation than White patients.

Despite all the progress achieved since Scribner first introduced the arteriovenous (AV) shunt in 1960 and Cimino and Brescia introduced the native AV fistula in 1962, we have continued to face a ...